Detalhe da pesquisa
1.
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).
Harm Reduct J
; 21(1): 104, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807133
2.
Determination of contaminants in artisanal cannabis products used for childhood epilepsy in the Australian community: A sub-analysis of the 'PELICAN' study.
Epilepsy Behav
; 127: 108496, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954507
3.
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
Harm Reduct J
; 19(1): 88, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907959
4.
The effect of cannabidiol on simulated car driving performance: A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol.
Hum Psychopharmacol
; 35(5): e2749, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729120
5.
Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
Harm Reduct J
; 17(1): 37, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513180
6.
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
Epilepsy Behav
; 70(Pt B): 334-340, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28238865
7.
Adolescent pre-treatment with oxytocin protects against adult methamphetamine-seeking behavior in female rats.
Addict Biol
; 21(2): 304-15, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25402719
8.
Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood.
Horm Behav
; 65(5): 488-96, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631584
9.
Active coping toward predatory stress is associated with lower corticosterone and progesterone plasma levels and decreased methylation in the medial amygdala vasopressin system.
Horm Behav
; 66(3): 561-6, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127982
10.
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review.
J Cannabis Res
; 6(1): 15, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509580
11.
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
PLoS One
; 19(2): e0297092, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354169
12.
Detection of Δ9 -tetrahydrocannabinol (THC) in oral fluid using two point-of-collection testing devices following oral administration of a THC and cannabidiol containing oil.
Drug Test Anal
; 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38414100
13.
A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa.
Psychoneuroendocrinology
; 164: 107032, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520886
14.
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.
Psychopharmacology (Berl)
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758300
15.
The "Next Day" Effects of Cannabis Use: A Systematic Review.
Cannabis Cannabinoid Res
; 8(1): 92-114, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475998
16.
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence.
Clin Transl Sci
; 16(1): 10-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259271
17.
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey.
Nat Sci Sleep
; 15: 245-255, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090897
18.
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey.
J Cannabis Res
; 5(1): 35, 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674243
19.
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.
BMJ Open
; 13(8): e071148, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612115
20.
How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials.
Drug Test Anal
; 15(3): 334-344, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478641